Synopsis
Synopsis
0
KDMF
0
VMF
0
Canada
DRUG PRODUCT COMPOSITIONS
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Chloramiphene
2. Citrate, Clomiphene
3. Clomid
4. Clomide
5. Clomifen
6. Clomifene
7. Clomiphene
8. Clomiphene Citrate
9. Clomiphene Hydrochloride
10. Clostilbegit
11. Dyneric
12. Gravosan
13. Hydrochloride, Clomiphene
14. Klostilbegit
15. Serophene
1. Clomiphene Citrate
2. 50-41-9
3. Zuclomiphene Citrate
4. Cis-clomiphene Citrate
5. Clomid
6. Zuclomid
7. Clomiphene A Citrate
8. 7619-53-6
9. Clomiphene Citrate Salt
10. Milophene
11. Serophene
12. (z)-clomiphene Citrate
13. Chloramiphene
14. Omifin
15. Rmi 16289
16. Clomivid
17. Clomphid
18. Dyneric
19. Genozym
20. Ikaclomin
21. Clomifene Citrate (serophene)
22. Zuclomiphene (citrate)
23. Uy5x264qzv
24. Mrl 41
25. Nsc-151466
26. 2-(4-(2-chloro-1,2-diphenylvinyl)phenoxy)-n,n-diethylethanamine 2-hydroxypropane-1,2,3-tricarboxylate
27. Nsc 35770
28. Rmi 16312
29. 2-[4-[(z)-2-chloro-1,2-diphenylethenyl]phenoxy]-n,n-diethylethanamine;2-hydroxypropane-1,2,3-tricarboxylic Acid
30. Ethanamine, 2-(4-((1z)-2-chloro-1,2-diphenylethenyl)phenoxy)-n,n-diethyl-, 2-hydroxy-1,2,3-propanetricarboxylate (1:1)
31. Ethanamine, 2-[4-(2-chloro-1,2-diphenylethenyl)phenoxy]-n,n-diethyl-,2-hydroxy-1,2,3-propanetricarboxylate (1:1)
32. Mer-41
33. Mrl-41
34. Unii-uy5x264qzv
35. Nsc 151466
36. Nsc-35770
37. Cas-50-41-9
38. Clomiphene Citrate, Cis-
39. Triethylamine, 2-(p-(2-chloro-1,2-diphenylvinyl)phenoxy)-, Citrate (1:1), (z)-
40. Mls001332629
41. Mls002207099
42. Schembl223472
43. Spectrum1500196
44. Sgcut00109
45. Chembl1213137
46. Hms501h04
47. Hy-b1617a
48. Hms1920o19
49. Hms2091g06
50. Hms2232d12
51. Pharmakon1600-01500196
52. Amy33425
53. Bcp03057
54. To_000032
55. Ccg-39553
56. Nsc151466
57. Nsc756698
58. S2561
59. Akos005111131
60. Bcp9000541
61. Ds-6814
62. Fd12066
63. Nsc-756698
64. Ncgc00017008-01
65. Ncgc00017008-02
66. Ncgc00017008-03
67. Ncgc00094626-01
68. Ncgc00094626-02
69. Ncgc00164385-01
70. Ac-19685
71. Ac-32011
72. Ethanamine, 2-(4-(2-chloro-1,2-diphenylethenyl)phenoxy)-n,n-diethyl-, (z)-, 2-hydroxy-1,2,3-propanetricarboxylate (1:1)
73. Bcp0726000214
74. Cs-0111663
75. Sw196898-3
76. C08161
77. Triethylamine,2-diphenylvinyl)phenoxy]-, Citrate
78. Sr-05000001591
79. Sr-05000001591-1
80. Q27291328
81. Triethylamine,2-diphenylvinyl)phenoxy]-, Citrate (1:1)
82. Triethylamine,2-diphenylvinyl)phenoxy]-, Citrate (1:1), (z)-
83. (2)2-[p-(2-chloro-1,2-diphenylvinyl)phenoxy]triethylamine Citrate (1:1)
84. 2-(4-[2-chloro-1,2-diphenylethenyl]phenoxy)-n,n-diethylethanamine Citrate Salt
85. {2-[4-(2-chloro-1,2-diphenylvinyl)phenoxy]ethyl}diethylamine 2-hydroxypropane-1,2,3-tricarboxylic Acid Salt
86. 2-({4-[(z)-2-chloro-1,2-diphenylethenyl]phenyl}oxy)-n,n-diethylethanamine 2-hydroxypropane-1,2,3-tricarboxylate (salt)
87. Ethanamine,2-diphenylethenyl)phenoxy]-n,n-diethyl-, (z)-, 2-hydroxy-1,2,3-propanetricarboxylate (1:1)
88. Ethanamine,2-diphenylethenyl)phenoxy]-n,n-diethyl-, 2-hydroxy-1,2,3-propanetricarboxylate (1:1)
| Molecular Weight | 598.1 g/mol |
|---|---|
| Molecular Formula | C32H36ClNO8 |
| Hydrogen Bond Donor Count | 4 |
| Hydrogen Bond Acceptor Count | 9 |
| Rotatable Bond Count | 14 |
| Exact Mass | 597.2129448 g/mol |
| Monoisotopic Mass | 597.2129448 g/mol |
| Topological Polar Surface Area | 145 Ų |
| Heavy Atom Count | 42 |
| Formal Charge | 0 |
| Complexity | 708 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 1 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
| 1 of 6 | |
|---|---|
| Drug Name | Clomid |
| PubMed Health | Clomiphene (By mouth) |
| Drug Classes | Endocrine-Metabolic Agent, Female Reproductive Agent |
| Drug Label | Clomiphene citrate tablets, USP is an orally administered, nonsteroidal, ovulatory stimulant designated chemically as 2-[p-(2chloro-1,2-diphenylvinyl)phenoxy] triethylamine citrate (1:1). It has the molecular formula of C26H28CINO C6H8O7 and a mo... |
| Active Ingredient | Clomiphene citrate |
| Dosage Form | Tablet |
| Route | Oral |
| Strength | 50mg |
| Market Status | Prescription |
| Company | Sanofi Aventis Us |
| 2 of 6 | |
|---|---|
| Drug Name | Clomiphene citrate |
| PubMed Health | Clomiphene (By mouth) |
| Drug Classes | Endocrine-Metabolic Agent, Female Reproductive Agent |
| Drug Label | ClomiPHENE citrate is an orally administered, nonsteroidal, ovulatory stimulant designated chemically as 2-[p-(2-chloro-1,2-diphenylvinyl) phenoxy] triethylamine citrate (1:1). It has a molecular formula of C26H28CINO C6H8O7 and a molecular weig... |
| Active Ingredient | Clomiphene citrate |
| Dosage Form | Tablet |
| Route | Oral |
| Strength | 50mg |
| Market Status | Prescription |
| Company | Par Pharm |
| 3 of 6 | |
|---|---|
| Drug Name | Serophene |
| Active Ingredient | Clomiphene citrate |
| Dosage Form | Tablet |
| Route | Oral |
| Strength | 50mg |
| Market Status | Prescription |
| Company | Emd Serono |
| 4 of 6 | |
|---|---|
| Drug Name | Clomid |
| PubMed Health | Clomiphene (By mouth) |
| Drug Classes | Endocrine-Metabolic Agent, Female Reproductive Agent |
| Drug Label | Clomiphene citrate tablets, USP is an orally administered, nonsteroidal, ovulatory stimulant designated chemically as 2-[p-(2chloro-1,2-diphenylvinyl)phenoxy] triethylamine citrate (1:1). It has the molecular formula of C26H28CINO C6H8O7 and a mo... |
| Active Ingredient | Clomiphene citrate |
| Dosage Form | Tablet |
| Route | Oral |
| Strength | 50mg |
| Market Status | Prescription |
| Company | Sanofi Aventis Us |
| 5 of 6 | |
|---|---|
| Drug Name | Clomiphene citrate |
| PubMed Health | Clomiphene (By mouth) |
| Drug Classes | Endocrine-Metabolic Agent, Female Reproductive Agent |
| Drug Label | ClomiPHENE citrate is an orally administered, nonsteroidal, ovulatory stimulant designated chemically as 2-[p-(2-chloro-1,2-diphenylvinyl) phenoxy] triethylamine citrate (1:1). It has a molecular formula of C26H28CINO C6H8O7 and a molecular weig... |
| Active Ingredient | Clomiphene citrate |
| Dosage Form | Tablet |
| Route | Oral |
| Strength | 50mg |
| Market Status | Prescription |
| Company | Par Pharm |
| 6 of 6 | |
|---|---|
| Drug Name | Serophene |
| Active Ingredient | Clomiphene citrate |
| Dosage Form | Tablet |
| Route | Oral |
| Strength | 50mg |
| Market Status | Prescription |
| Company | Emd Serono |
Fertility Agents, Female
Compounds which increase the capacity to conceive in females. (See all compounds classified as Fertility Agents, Female.)
Estrogen Antagonists
Compounds which inhibit or antagonize the action or biosynthesis of estrogenic compounds. (See all compounds classified as Estrogen Antagonists.)
Selective Estrogen Receptor Modulators
A structurally diverse group of compounds distinguished from ESTROGENS by their ability to bind and activate ESTROGEN RECEPTORS but act as either an agonist or antagonist depending on the tissue type and hormonal milieu. They are classified as either first generation because they demonstrate estrogen agonist properties in the ENDOMETRIUM or second generation based on their patterns of tissue specificity. (Horm Res 1997;48:155-63) (See all compounds classified as Selective Estrogen Receptor Modulators.)
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]CEP/COS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] EU WC
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]NDC API
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
| Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
|---|
Upgrade, download data, analyse, strategize, subscribe with us 
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]INTERMEDIATE SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDA Orange Book
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Europe
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Australia
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Related Excipient Companies
SPI Pharma
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Faran Shimi Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Gangwal Healthcare
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Nanjing Well Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Pfanstiehl
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Actylis
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Anhui Sunhere Pharmaceutical Excipients Co.,Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]DFE Pharma
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Gangwal Chemicals
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Ideal Cures
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Ingredion Pharma Solutions
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Kerry
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Microlex e.U
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Nitika Pharmaceutical Specialities
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Pharmatrans-Sanaq
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Pluviaendo
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Prachin Chemical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Roquette
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Seppic
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Shanghai Shenmei Pharmaceutical Technology Co., Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Sigachi Industries
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Excipients by Applications
Fillers, Diluents & Binders
Disintegrants & Superdisintegrants
Direct Compression
Co-Processed Excipients
Thickeners and Stabilizers
Granulation
Lubricants & Glidants
Taste Masking
Coating Systems & Additives
Chewable & Orodispersible Aids
Controlled & Modified Release
Emulsifying Agents
Parenteral
Film Formers & Plasticizers
API Stability Enhancers
Rheology Modifiers
Digital Content
NEWS #PharmaBuzz
Global Sales Information
US Medicaid Prescriptions
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Market Place
Patents & EXCLUSIVITIES
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
50
PharmaCompass offers a list of Clomiphene Citrate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Clomiphene Citrate manufacturer or Clomiphene Citrate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Clomiphene Citrate manufacturer or Clomiphene Citrate supplier.
PharmaCompass also assists you with knowing the Clomiphene Citrate API Price utilized in the formulation of products. Clomiphene Citrate API Price is not always fixed or binding as the Clomiphene Citrate Price is obtained through a variety of data sources. The Clomiphene Citrate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Ardomon manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Ardomon, including repackagers and relabelers. The FDA regulates Ardomon manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Ardomon API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Ardomon manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Ardomon supplier is an individual or a company that provides Ardomon active pharmaceutical ingredient (API) or Ardomon finished formulations upon request. The Ardomon suppliers may include Ardomon API manufacturers, exporters, distributors and traders.
click here to find a list of Ardomon suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Ardomon DMF (Drug Master File) is a document detailing the whole manufacturing process of Ardomon active pharmaceutical ingredient (API) in detail. Different forms of Ardomon DMFs exist exist since differing nations have different regulations, such as Ardomon USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Ardomon DMF submitted to regulatory agencies in the US is known as a USDMF. Ardomon USDMF includes data on Ardomon's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Ardomon USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Ardomon suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Ardomon Drug Master File in Japan (Ardomon JDMF) empowers Ardomon API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Ardomon JDMF during the approval evaluation for pharmaceutical products. At the time of Ardomon JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Ardomon suppliers with JDMF on PharmaCompass.
A Ardomon CEP of the European Pharmacopoeia monograph is often referred to as a Ardomon Certificate of Suitability (COS). The purpose of a Ardomon CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Ardomon EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Ardomon to their clients by showing that a Ardomon CEP has been issued for it. The manufacturer submits a Ardomon CEP (COS) as part of the market authorization procedure, and it takes on the role of a Ardomon CEP holder for the record. Additionally, the data presented in the Ardomon CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Ardomon DMF.
A Ardomon CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Ardomon CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Ardomon suppliers with CEP (COS) on PharmaCompass.
A Ardomon written confirmation (Ardomon WC) is an official document issued by a regulatory agency to a Ardomon manufacturer, verifying that the manufacturing facility of a Ardomon active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Ardomon APIs or Ardomon finished pharmaceutical products to another nation, regulatory agencies frequently require a Ardomon WC (written confirmation) as part of the regulatory process.
click here to find a list of Ardomon suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Ardomon as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Ardomon API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Ardomon as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Ardomon and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Ardomon NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Ardomon suppliers with NDC on PharmaCompass.
Ardomon Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Ardomon GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Ardomon GMP manufacturer or Ardomon GMP API supplier for your needs.
A Ardomon CoA (Certificate of Analysis) is a formal document that attests to Ardomon's compliance with Ardomon specifications and serves as a tool for batch-level quality control.
Ardomon CoA mostly includes findings from lab analyses of a specific batch. For each Ardomon CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Ardomon may be tested according to a variety of international standards, such as European Pharmacopoeia (Ardomon EP), Ardomon JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Ardomon USP).
